Liver Venous Deprivation
Cross-source consensus on Liver Venous Deprivation from 1 sources and 5 claims.
1 sources · 5 claims
Benefits
Comparisons
Highlighted claims
- LVD produces significantly greater hypertrophy than PVEfLR. — Impact of portal vein embolisation uses in colorectal liver metastases: evidence from a rapid review
- LVD has a significantly faster kinetic growth rate than PVEfLR. — Impact of portal vein embolisation uses in colorectal liver metastases: evidence from a rapid review
- Neither LVD nor PVEfLR had any mortality within 90 days in the one comparison study. — Impact of portal vein embolisation uses in colorectal liver metastases: evidence from a rapid review
- The PVEfLR group had no adverse events in the LVD comparison study, whereas the LVD group experienced four mild or moderate adverse events. — Impact of portal vein embolisation uses in colorectal liver metastases: evidence from a rapid review
- Post-intervention standardised FLR index was higher with LVD than PVEfLR, but not significantly so. — Impact of portal vein embolisation uses in colorectal liver metastases: evidence from a rapid review